Suchergebnisse

Two lowest-energy odd-parity atomic levels of actinium, 7s27pP21/2o, 7s27pP23/2o, were observed via two-step resonant laser-ionization spectroscopy and their respective energies were measured to be 7477.36(4) and 12 276.59(2) cm-1. The lifetimes of these states were determined as 668(11) and 255(7) ns, respectively. In addition, we observed the effect of the hyperfine structure on the line for the transition to P23/2o. These properties were calculated using a hybrid approach that combines configuration interaction and coupled-cluster methods, in good agreement with the experiment. The data are of relevance for understanding the complex atomic spectra of actinides and for developing efficient laser cooling and ionization schemes for actinium, with possible applications for high-purity medical-isotope production and future fundamental physics experiments. © 2020 American Physical Society. ; The authors thank V. V. Flambaum and V. A. Dzuba for stimulating discussions and providing the corrected lifetimes, and M. Block, Ch. Mokry, and J. Runke for providing the actinium sample. We gratefully acknowledge discussions with R. Beerwerth and S. Fritzsche on the theory of the actinium hyperfine structure. The work was supported by the German Federal Ministry of Education and Research under the Projects No. 05P15UMCIA, No. 05P18UMCIA. D. B. was supported in part by the DFG Project ID 390831469: EXC 2118 (). D. B. also received support from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (Grant Agreement No. 695405), from the DFG Reinhart Koselleck Project. Theory work was supported in part by U.S. NSF Grant No. PHY-1620687. S. G. P. and M. G. K. acknowledge support by the Russian Science Foundation under Grant No. 19-12-00157.

Laser resonance ionization spectroscopy was performed on the rare einsteinium isotopes Es253-255 at the RISIKO mass separator in Mainz. With low sample sizes ranging down to femtograms, the prominent 352 nm-ground-state transition was measured in all three einsteinium isotopes, and four additional ground-state transitions were measured in Es254. Hyperfine-structure analysis resulted in assigned spin values of I(Es254)=7 and I(Es255)=7/2. From the extracted coupling constants, nuclear magnetic dipole moments of μI(Es254)=3.42(7)μN and μI(Es255)=4.14(10)μN as well as spectroscopic electric quadrupole moments of Qs(Es254)=9.6(1.2)eb and Qs(Es255)=5.1(1.7)eb were derived. Our value for Es254 deviates from the value of |μI(Es254)|=4.35(41)μN extracted from the angular anisotropy of α-radiation emitted by Es254. © 2022 authors. Published by the American Physical Society. ; Acknowledgments. This research was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program, under Award DE-FG02-13ER16414. The isotopes used in this research were supplied by the U.S. DOE Isotope Program, managed by the Office of Science. This work has been supported by the Bundesministerium für Bildung und Forschung (BMBF, Germany) under Project No. 05P18UMCIA. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 861198–LISA–H2020-MSCA-ITN-2019.

The β−-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer diseases. It can be produced in nuclear research reactors, irradiating isotopically-enriched 168Er2O3. This path, however, is not suitable for receptor-targeted radionuclide therapy, where high specific molar activities are required. In this study, an electromagnetic isotope separation technique was applied after neutron irradiation to boost the specific activity by separating 169Er from 168Er targets. The separation efficiency increased up to 0.5% using resonant laser ionization. A subsequent chemical purification process was developed as well as activity standardization of the radionuclidically pure 169Er. The quality of the 169Er product permitted radiolabeling and pre-clinical studies. A preliminary in vitro experiment was accomplished, using a 169Er-PSMA-617, to show the potential of 169Er to reduce tumor cell viability. © Copyright © 2021 Talip, Borgna, Müller, Ulrich, Duchemin, Ramos, Stora, Köster, Nedjadi, Gadelshin, Fedosseev, Juget, Bailat, Fankhauser, Wilkins, Lambert, Marsh, Fedorov, Chevallay, Fernier, Schibli and van der Meulen. ; The authors thank CERN ISOLDE and RILIS teams for the laser operation (Maxim D. Seliverstov, Katerina Chrysalidis), radiation protection and logistic teams of PSI (Tobias Schneider) and CERN (Alexandre Dorsival, Matthieu Deschamps and Elodie Aubert, Philippe Bertreix, Nicolas Riggaz, Nabil Menaa, Aurore Boscher, Jeremie Comte, Benjamin Juif); the LARISSA workgroup of Mainz University for the laser preparation and erbium laser ionization scheme development (Prof. Dr. Klaus Wendt and Dr. Dominik Studer). The authors are grateful to Fan Sozzi-Guo, Muhamet Djelili, Alexander V?gele and Walter Hirzel (PSI) and Bernard Cr?pieux, Giacomo Lunghi, Francesco Riccardi, Miranda Van Stenis, Thomas Schneider (CERN) for technical support. Funding. ZT and NM received funding from the Swiss National Science Foundation (SNF Grant Number: 200021_188495). CM obtained funding for this project from the Swiss Cancer Research (KFS-4678-02-2019-R). FB received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sk?odowska-Curie Grant Agreement No 701647.